Flyer

Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

A case report of clinical-therapeutic failure of Dalbavancin in a patient with a vascular ulcer infected from MRSA

Congresso Regionale Fadoi Campania 2023 Cdc 231 (proceedings of XXII Congress of Fadoi Campania)
22 September 2023, Italy

N. Capoluongo, A. Bernardo, A. Fioretti, S. Scarica, A. Izzi and A. Perrella

UOC Emerging Infectious Disease with High Contagiousness, AORN Ospedali dei Colli P.O. Cotugno, 80131 Naples, Italy.
UOC Clinical Pathology, AORN Ospedali dei Colli P.O. Cotugno, Naples 80131, Italy.
UOSD Hemergency Room, AORN Ospedali dei Colli P.O. C Cotugno, 80131 Naples, Italy.

Scientific Tracks Abstracts: Health Sci J

Abstract:

Skin and soft tissue infections (SSTIs) are an important cause of hospitalization. The most common pathogens causing SSTI are Streptococci and Staphylococcus Aureus, especially methicillinresistant S. aureus (MRSA). Case report A 72-year-old woman with confirmed ischemic heart disease, type 2 diabetes mellitus, severe peripheral vascular disease, stage III chronic renal failure, severe obesity, was hospitalized to the Cardarelli hospital in Naples, from 10 March as of March 17, 2022, for left upper leg ulcer infection from MRSA. She was treated with Dalabavancin 1500 mg in one dose and this patient began to show a worsening of the clinical and laboratory picture, and on 17 March she was transferred to the first division of the Cotugno hospital of Naples. MRSA isolated from left upper leg ulcer showed sensitivity to dalbavancin with an MIC of 0.125 mg/L near the resistance breaking point (S ≤ 0.125 mg/L; R > 0.125 mg/L). The minimal inhibitory concentration (MIC) of dalbavancin was detected using E-test strips. From the culture examination of the upper left leg ulcer the presence of methicillin resistant Staphylococcus aureus. This MRSA showed, also, sensitivity to Linezolid (MIC 2), Vancomycin (MIC 2), and Daptomycin (MIC 1). Given the acute over chronic renal failure due to the patient's septic state and given the good tissue penetration of linezolid, this antibiotic was opted for with resolution of septic symptoms and laboratory parameters. In our case report, Staphylococcus aureus was identified by Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) Biomérieux S.p.A., Italy), from wound swabs sample. The susceptibility of Staphylococcus aureus strains to all antibiotics, except Dalbavancin, was investigated using Vitek II (Biomérieux S.p.A., Italy), and (Sensititre, ThermoFisher) following the manufacturer’s instructions. Dalbavancin minimum inhibitory concentration (MIC) was detected using E-test strips (Liofilchem Diagnostici) MRSA infection worsens venous insufficiency: Neutrophils play an essential role in the innate immune response, providing the first line of host defense. It has recently been shown that these cells can trap and kill microorganisms by releasing neutrophil extracellular traps (NETs) composed of chromatin and antimicrobial proteins. Following the manufacturer’s instructions. Results were interpreted using EUCAST breakpoint. Conclusion In our case report we highlight the presence of MRSA with MIC at the limits of sensitivity for Dalbavancin. It is important to use antibiotics appropriately, including the causative agent and appropriate reading of the antibiograms, site of action, patient type, antibiotic dosage and duration of therapy.
References :
1. Moffarah AS, Mohajer M, Hurwitz BL, Armstrong DG (2016) Skin and Soft Tissue Infections. Microbiol Spectra 4.
2. Peetermans M, de Prost N, Eckmann C, Norrby-Teglund A, Skrede S (2020) Necrotizing skin and soft-tissue infections in the intensive care unit. Clin Microbiol Infect 8-17.